Serum HDL cholesterol values are associated with apoB-containing lipoprotein metabolism and triglyceride-body fat interrelation in young Japanese men

Atherosclerosis

Volumn 130, Issue 1-2, 1997, Pages 93-100

  Kazumi, Tsutomu ^a   Kawaguchi, Akira ^b   Hozumi, Toshiki ^c   Ishida, Yoshihiko ^c   Yoshino, Gen ^d  

^a Hyogo Rehabilitation Center Hospital   (Japan)

^b KOBE UNIVERSITY OF MERCANTILE MARINE   (Japan)

^c HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^d TOHO UNIVERSITY   (Japan)

Author keywords

ApoAI; ApoB; ApoE; HDL cholesterol; percent body fat; triglyceride

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; HUMAN; JAPAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADOLESCENT; ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BODY CONSTITUTION; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; JAPAN; MALE; TRIGLYCERIDES;

EID: 0030990548     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06049-2     Document Type: Article

References (33)

1. Jacobs DR, Mebane IL, Bangdiwela SI, Crigui MH, Tyroler HA, for the Lipid Research Clinics Program. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990;131:32-47.
2. Pekkanen J, Linn S, Heiss G, Suchhindran CM, Leon A, Rifkind BM, Tyroler HA. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990;322:1700-1707.
3. Paunio M, Heinonen OP, Virtamo J, Klag MJ, Manninen V, Albanes D, Comstock GW. HDL cholesterol and mortality in Finnish men with special reference to alcohol intake. Circulation 1994;90:2909-2918.
4. Kitamura A, Iso H, Naito Y, Iida M, Konishi M, Folson AR, Sato S, Kiyama M, Nakamura M, Sankai T. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 1994;89:2533-2539.
5. The Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). J Am Med Assoc 1993;269:3015-3023.
6. Brinton EA, Eisenberg S, Breslow JL. Human HDL cholesterol levels are determined by apoAI fractional catabolic rate, which correlates inversely with estimates of HDL size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels and body fat distribution. Arterioscler Thromb 1994;14:707-720.
7. Freeman DJ, Griffin BA, Holmes AP, Lindsay GM, Gaffney D, Packard CJ, Shepherd J. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 1994;14:336-344.
8. Cohen J, Wang Z, Grundy S, Stoestz M, Guerra R. Variation of the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 1994;94:2377-2384.
9. Tall AR. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest 1990;86:379-384.
10. Brozek J, Grande F, Anderson JT, Keys A. Densitometric analysis of body composition: reversion of some quantitative assumptions. Ann NY Acad Sci 1963;110:113-140.
11. Sakamoto Y, Sato T, Aikei M, Ohno M, Ikeda Y. Evaluation of body fat using bioelectrical impedance analysis. Proc of the 12th Congress of Japan Society for the Study of Obesity (JASSO). Tokyo: JASSO, 1992;229-280 (in Japanese).
12. Bray GA. Complications of obesity. Ann Intern Med 1985;103:1052-1062.
13. 2+ precipitation procedure for quantitation of high density lipoprotein cholesterol. Clin Chem 1982;28:1379-1388.
14. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973;19:1350-1356.
15. Sullivan DR, Kruijswijk Z, West CE, Kohlmeier M, Katan MB. Determination of serum triglyceride by an accurate enzymatic method not affected by free glycerol. Clin Chem 1985;31:1227-1228.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
17. Ikeda T, Shibuya Y, Senba U, Sugiuchi H, Araki S, Uji Y, Okabe H. Automated immunoturbidometric analysis of six plasma apolipoproteins: correlation with radial immunodiffusion assays. J Clin Lab Anal 1991;5:90-95.
18. Bergström E, Hernell O, Persson LÅ, Vessby B. Serum lipid values in adolescents are related to family history, infant feeding, and physical growth. Atherosclerosis 1995;117:1-13.
19. Simons LA. Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol 1986;57:5-10.
20. Schaefer EJ, Levy RI, Anderson DW, Danner RN, Brewer HB Jr, Blackwelder WC. Plasma triglycerides in regulations of HDL-cholesterol levels. Lancet 1978;2:391-393.
21. Schaefer EJ, Zech LA, Jenkins LL, Bronzert TJ, Rubalcaba EA, Lindgren FT, Aamodt RL, Brewer HB Jr. Human apolipoprotein A-I and A-II metabolism. J Lipid Res 1982;23:850-862.
22. Schaefer EJ, Ordovas JM. Metabolism of the apolipoproteins A-I, A-II and A-IV. Methods Enzymol 1986;129:420-422.
23. Brinton EA, Eisenberg S, Breslow JL. Increased apo-AI and apo-AII fractional catabolic rate in patients with low high density lipoprotein cholesterol levels with or without hypertriglyceridemia. J Clin Invest 1991;87:536-544.
24. Widhalm K. Pediatric guidelines for lipid reduction. Eur Heart J 1987;8:67-70.
25. Ginsberg HN, Le N-A, Gibson JC. Regulation of production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects: the effects of weight loss. J Clin Invest 1985;75:614-623.
26. Teng B, Sniderman AD, Soutar AK, Thompson GR. Metabolic basis of hyperapobetalipoproteinemia: turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J Clin Invest 1986;77:663-672.
27. Kissebah AH, Alfarsi S, Adamo PW. Integrated regulation of very low density lippoprotein triglyceride and apolipoprotein-B kinetics in man: normolipidemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metabolism 1981;30:856-868.
28. Arad Y, Ramakrishnan R, Ginsberg HN. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production. J Lipid Res 1990;31:567-582.
29. Elovson J, Chatterton JE, Bell GT, Schumaker VN, Reuben MA, Puppione DL, Reeve Jr JR, Young NL. Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J Lipid Res 1988;29:1461-1473.
30. Gylling H, Vega GL, Grundy SM. Physiologic mechanisms for reduced apolipoprotein AI concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. J Lipid Res 1992;33:1527-1539.
31. World Health Organization Study Group. Diet, nutrition and the prevention of chronic diseases. World Health Organization Technical Report Series 797, Geneva, 1990;69-75.
32. Anderson AJ, Sobocinski KA, Freedman DS, Barboriak JJ, Rimm AA, Gruchow HW: Body fat distribution, plasma lipids and lipoproteins. Arteriosclerosis 1988;8:88-94.
33. Schaefer EJ, Lamon-Fava S, Ordovas JM, Cohn SD, Schaefer MM, Castelli WP, Wilson WF. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein AI levels in the Framingham Offspring Study. J Lipid Res 1994;35:871-882.